nach oben

Erschienen in:

01.09.2011 | Nephrology – Original Paper

Correlation between cathepsin D serum concentration and carotid intima-media thickness in hemodialysis patients

verfasst von: Seyed Adel Moallem, Fatemeh Nazemian, Sepideh Eliasi, Seyed Ali Alamdaran, Jamal Shamsara, Amir Hooshang Mohammadpour

Erschienen in: International Urology and Nephrology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Aim

Cardiovascular (CV) disease is the leading cause of death in hemodialysis (HD) patients, and approximately half of mortalities in HD patients are attributed to CV disease. Atherosclerosis is the most frequent cause of CV complications in patients with end-stage renal disease (ESRD). Based on recent studies, cathepsin D has been suggested as a potential marker of atherosclerosis, and we hypothesized that there is an association between serum concentration of cathepsin D and carotid intima-media thickness (CIMT) in hemodialysis patients.

Methods

Thirty-one hemodialysis patients (18 men and 13 women) were enrolled in this study. Serum levels of soluble cathepsin D were measured with an enzyme-linked immunosorbant assay (ELISA) kit. CIMT was determined in each patient.

Results

The data showed that there was a positive significant correlation between serum concentration of cathepsin D and CIMT by using Pearson correlation (P value <0.05).

Conclusion

Based on the results of this study, cathepsin D could be suggested to have a role in the development of atherosclerotic plaques.

Bevc S, Hojs R, Ekart R et al (2006) Atherosclerosis in hemodialysis patients: traditional and nontraditional risk factors. Acta Dermatovenerol Alp Panonica Adriat 15(4):151–157PubMed

Tsushima M, Terayama Y, Momose A et al (2008) Progression of atherosclerosis in hemodialysis patients: effect of adiponectin on carotid intima media thickness. J Atheroscler Thromb 15(4):213–218PubMedCrossRef

Kawagishi T, Nishizawa Y, Konishi T et al (1995) High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48(3):820–826PubMedCrossRef

Lepedda AJ, Cigliano A, Cherchi GM et al (2008) A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 203:112–118PubMedCrossRef

Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868–874PubMedCrossRef

Lutgens E, van Suylen RJ, Faber BC et al (2003) Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb Vasc Biol 23(12):2123–2130PubMedCrossRef

Stoneman VE, Bennett MR (2004) Role of apoptosis in atherosclerosis and its therapeutic implications. Clin Sci (Lond) 107(4):343–354CrossRef

Duran MC, Martin-Ventura JL, Mohammed S et al (2007) Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. Eur J Pharmacol 562(1–2):119–129PubMedCrossRef

Mitra AK, Dhume AS, Agrawal DK (2004) “Vulnerable plaques”—ticking of the time bomb. Can J Physiol Pharmacol 82(10):860–871PubMedCrossRef

10.

Vivanco F, Martin-Ventura JL, Duran MC et al (2005) Quest for novel cardiovascular biomarkers by proteomic analysis. J Proteome Res 4(4):1181–1191PubMedCrossRef

11.

Barderas MG, Dardé VM, de la Cuesta F et al (2008) Proteomic analysis of circulating monocytes identifies cathepsin D as a potential novel plasma marker of acute coronary syndromes. Clin Med: Cardiol 2:191–200

12.

Jormsjo S, Wuttge DM, Sirsjo A et al (2002) Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 161(3):939–945PubMedCrossRef

13.

Hakala JK, Oksjoki R, Laine P et al (2003) Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 23(8):1430–1436PubMedCrossRef

14.

Benes P, Vetvicka V, Fusek M (2008) Cathepsin D—many functions of one aspartic protease. Crit Rev Oncol Hematol 68(1):12–28PubMedCrossRef

15.

Liu J, Sukhova GK, Sun JS et al (2004) Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 24(8):1359–1366PubMedCrossRef

16.

Lutgens SP, Cleutjens KB, Daemen MJ et al (2007) Cathepsin cysteine proteases in cardiovascular disease. Faseb J 21(12):3029–3041PubMedCrossRef

17.

Ward MR, Pasterkamp G, Yeung AC et al (2000) Arterial remodeling. Mechanisms and clinical implications. Circulation 102(10):1186–1191PubMed

18.

Cooper JB (2002) Aspartic proteinases in disease: a structural perspective. Curr Drug Targets 3(2):155–173PubMedCrossRef

19.

Miller BF, Kothari HV (1969) Increased activity of lysosomal enzymes in human atherosclerotic aortas. Exp Mol Pathol 10(3):288–294PubMedCrossRef

20.

Lorenz MW, Markus HS, Bots ML et al (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115(4):459–467PubMedCrossRef

21.

Simon A, Gariepy J, Chironi G et al (2002) Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 20(2):159–169PubMedCrossRef

22.

Aminbakhsh A, Mancini GB (1999) Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. Clin Invest Med 22(4):149–157PubMed

23.

Greenland P, Abrams J, Aurigemma GP et al (2000) Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 101(1):E16–E22PubMed

24.

Hellings WE, Peeters W, Moll FL et al (2007) From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization. Trends Cardiovasc Med 17(5):162–171PubMedCrossRef

25.

Naghavi M, Libby P, Falk E et al (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108(14):1664–1672PubMedCrossRef

26.

Delucchi A, Dinamarca H, Gainza H et al (2008) Carotid intima-media thickness as a cardiovascular risk marker in pediatric end-stage renal disease patients on dialysis and in renal transplantation. Transplant Proc 40(9):3244–3246PubMedCrossRef

27.

Li W, Yuan X (2006) Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis. Ann N Y Acad Sci 1030(1):427–433CrossRef

28.

Chen GC, Liu W, Duchateau P et al (1994) Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects. J Biol Chem 269(46):29121–29128PubMed

29.

Strojan P, Budihna M, Smid L et al (1998) Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck. Cancer Lett 130(1–2):49–56PubMedCrossRef

30.

Anim JT, John B, Abdulsathar SS et al (2005) Relationship between the expression of various markers and prognostic factors in breast cancer. Acta Histochem 107(2):87–93PubMedCrossRef

31.

Takato T, Yamada N, Ashida T (2008) Effects of aging and sex on progression of carotid intima-media thickness: a retrospective 6-year follow-up study. Geriatr Gerontol Int 8(3):172–179PubMedCrossRef

32.

Fan AZ, Paul-Labrador M, Merz CN et al (2006) Smoking status and common carotid artery intima-medial thickness among middle-aged men and women based on ultrasound measurement: a cohort study. BMC Cardiovasc Disord 6:42PubMedCrossRef

Titel: Correlation between cathepsin D serum concentration and carotid intima-media thickness in hemodialysis patients
verfasst von: Seyed Adel Moallem
Fatemeh Nazemian
Sepideh Eliasi
Seyed Ali Alamdaran
Jamal Shamsara
Amir Hooshang Mohammadpour
Publikationsdatum: 01.09.2011
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 3/2011
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-010-9729-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2011

The effect of kidney diseases on survival in liver transplant patients

Creatinine clearance with cimetidine in the elderly: response to Dr. Chia-Ter Chao

Does intubated uretero-ureterocutaneostomy provide better health-related quality of life than orthotopic neobladder in patients after radical cystectomy for invasive bladder cancer?

The role of obesity in kidney disease: recent findings and potential mechanisms

Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms